Total Value
$771.90B
Holdings Count
17
Period of Report
Jun 30, 2025
Report Type
HR
| Issuer | CUSIP | Value | Shares |
|---|---|---|---|
| APOGEE THERAPEUTICS INC | 03770N101 | $88.97B | 2,048,647 |
| AXSOME THERAPEUTICS INC | 05464T104 | $85.10B | 815,176 |
| ENLIVEN THERAPEUTICS INC | 29337E102 | $74.45B | 3,711,444 |
| SCHOLAR ROCK HLDG CORP | 80706P103 | $64.61B | 1,824,031 |
| SPYRE THERAPEUTICS INC | 00773J202 | $60.15B | 4,018,101 |
| NUVALENT INC | 670703107 | $55.51B | 727,563 |
| DIANTHUS THERAPEUTICS INC | 252828108 | $50.43B | 2,707,191 |
| KINIKSA PHARMACEUTICALS INTL | G52694109 | $49.05B | 1,772,839 |
| VIRIDIAN THERAPEUTICS INC | 92790C104 | $48.37B | 3,459,913 |
| COGENT BIOSCIENCES INC | 19240Q201 | $44.70B | 6,225,641 |
| ORUKA THERAPEUTICS INC | 687604108 | $37.80B | 3,371,922 |
| JADE BIOSCIENCES INC | 008064206 | $32.17B | 3,220,368 |
| CRESCENT BIOPHARMA INC. | G2545C104 | $22.40B | 1,387,866 |
| ASTRIA THERAPEUTICS INC | 04635X102 | $19.05B | 3,554,129 |
| ZENAS BIOPHARMA INC | 98937L105 | $18.34B | 1,892,806 |
| INHIBIKASE THERAPEUTICS INC | 45719W205 | $11.94B | 6,125,000 |
| CYTOMX THERAPEUTICS INC | 23284F105 | $8.85B | 3,896,582 |